539997 — Kwality Pharmaceuticals Cashflow Statement
0.000.00%
- IN₹7.82bn
- IN₹8.75bn
- IN₹3.07bn
- 93
- 25
- 70
- 71
Annual cashflow statement for Kwality Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | R2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | Interim Report | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 109 | 213 | 1,616 | 256 | 311 |
Depreciation | |||||
Non-Cash Items | 26.5 | 26 | 28.7 | 59.9 | 171 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -118 | -36.6 | -1,145 | -51.4 | -247 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 61.6 | 267 | 606 | 414 | 430 |
Capital Expenditures | -208 | -234 | -552 | -477 | -298 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 29.8 | 1.97 | -77.8 | -7.68 | 34.4 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -178 | -232 | -629 | -484 | -264 |
Financing Cash Flow Items | 66.8 | -26.7 | -29.2 | -60.2 | -102 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 118 | 7.67 | 56.6 | 9.94 | -174 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.38 | 42.7 | 33.3 | -60.6 | -8.12 |